{"id":"https://openalex.org/W2008790685","doi":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","title":"Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra\u2010low\u2010molecular\u2010weight heparin, AVE5026","display_name":"Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra\u2010low\u2010molecular\u2010weight heparin, AVE5026","alternate_titles":[],"publication_year":2009,"publication_date":"2009-04-27","ids":{"openalex":"https://openalex.org/W2008790685","doi":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","mag":"2008790685","pmid":"https://pubmed.ncbi.nlm.nih.gov/19422447"},"language":"en","primary_location":{"id":"doi:10.1111/j.1538-7836.2009.03447.x","doi":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","pdf_url":null,"source":{"id":"https://openalex.org/S164469042","display_name":"Journal of Thrombosis and Haemostasis","issn_l":"1538-7836","issn":["1538-7836","1538-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thrombosis and Haemostasis","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2008790685"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011613349","display_name":"Christian Viskov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]},{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE","FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"C. VISKOV","raw_affiliation_strings":["Chemical & Analytical Sciences, Research and Development, Sanofi-Aventis, Vitry-Sur-Seine, France. Christian.Viskov@sanofi-aventis.com","Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical & Analytical Sciences, Research and Development, Sanofi-Aventis, Vitry-Sur-Seine, France. Christian.Viskov@sanofi-aventis.com","institution_ids":["https://openalex.org/I3018075036"]},{"raw_affiliation_string":"Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany","institution_ids":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016162464","display_name":"Melitta Just","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]},{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE","FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. JUST","raw_affiliation_strings":["Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany","institution_ids":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045257458","display_name":"Volker Laux","orcid":"https://orcid.org/0000-0003-0891-3683","observed_orcids":["https://orcid.org/0000-0003-0891-3683"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. LAUX","raw_affiliation_strings":["Acute Care Research, Bayer Schering Pharma, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acute Care Research, Bayer Schering Pharma, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032646611","display_name":"Pierre A. J. Mourier","orcid":"https://orcid.org/0000-0003-1629-3816","observed_orcids":["https://orcid.org/0000-0003-1629-3816"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]},{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE","FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. MOURIER","raw_affiliation_strings":["Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany","institution_ids":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073494000","display_name":"M. Lorenz","orcid":"https://orcid.org/0000-0001-8362-9346","observed_orcids":["https://orcid.org/0000-0001-8362-9346"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]},{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE","FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. LORENZ","raw_affiliation_strings":["Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Sanofi\u2010Aventis, Vitry/France, Frankfurt/Germany","institution_ids":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5011613349","https://openalex.org/A5073494000"],"corresponding_institution_ids":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":7.6833,"has_fulltext":false,"cited_by_count":65,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96877666,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"7","issue":"7","first_page":"1143","last_page":"1151"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.7348999977111816,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.7348999977111816,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.25049999356269836,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heparin-depolymerization","display_name":"heparin depolymerization","score":0.8690000176429749},{"id":"https://openalex.org/keywords/phosphazene-base","display_name":"phosphazene base","score":0.8830000162124634},{"id":"https://openalex.org/keywords/anti-xa-activity","display_name":"anti-Xa activity","score":0.9279999732971191},{"id":"https://openalex.org/keywords/anti-factor-iia-activity","display_name":"anti-factor IIa activity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/thrombin-inhibition","display_name":"thrombin inhibition","score":0.8320000171661377},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.8960000276565552},{"id":"https://openalex.org/keywords/arterial-thrombosis","display_name":"arterial thrombosis","score":0.9340000152587891},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C42533223","wikidata":"https://www.wikidata.org/wiki/Q1378064","display_name":"ED50","level":3,"score":0.8864805698394775},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.7828762531280518},{"id":"https://openalex.org/C2776884760","wikidata":"https://www.wikidata.org/wiki/Q2750727","display_name":"Low molecular weight heparin","level":3,"score":0.7737143039703369},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.7163492441177368},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.6452319025993347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.614318311214447},{"id":"https://openalex.org/C2778825682","wikidata":"https://www.wikidata.org/wiki/Q416516","display_name":"Enoxaparin sodium","level":4,"score":0.545617938041687},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5404580235481262},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.5235556960105896},{"id":"https://openalex.org/C49852136","wikidata":"https://www.wikidata.org/wiki/Q906487","display_name":"Depolymerization","level":2,"score":0.4855332374572754},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.46780067682266235},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.46121490001678467},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.4512939155101776},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.44758760929107666},{"id":"https://openalex.org/C2779216453","wikidata":"https://www.wikidata.org/wiki/Q489957","display_name":"Bleeding time","level":4,"score":0.44427067041397095},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4288896918296814},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.41543814539909363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24123987555503845},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.14604344964027405},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.10937002301216125},{"id":"https://openalex.org/C2993802102","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet aggregation","level":3,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002846","descriptor_name":"Chromatography, Affinity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002850","descriptor_name":"Chromatography, Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011516","descriptor_name":"Prothrombin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017984","descriptor_name":"Enoxaparin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1538-7836.2009.03447.x","doi":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","pdf_url":null,"source":{"id":"https://openalex.org/S164469042","display_name":"Journal of Thrombosis and Haemostasis","issn_l":"1538-7836","issn":["1538-7836","1538-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmid:19422447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19422447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of thrombosis and haemostasis : JTH","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1538-7836.2009.03447.x","doi":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1538-7836.2009.03447.x","pdf_url":null,"source":{"id":"https://openalex.org/S164469042","display_name":"Journal of Thrombosis and Haemostasis","issn_l":"1538-7836","issn":["1538-7836","1538-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thrombosis and Haemostasis","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1516766157","https://openalex.org/W1517218704","https://openalex.org/W1537999925","https://openalex.org/W1837090086","https://openalex.org/W1968380720","https://openalex.org/W1981370196","https://openalex.org/W1991285364","https://openalex.org/W1996647408","https://openalex.org/W2001790577","https://openalex.org/W2004878316","https://openalex.org/W2014396085","https://openalex.org/W2018585677","https://openalex.org/W2023320697","https://openalex.org/W2027330966","https://openalex.org/W2037446571","https://openalex.org/W2038363212","https://openalex.org/W2049482121","https://openalex.org/W2058073930","https://openalex.org/W2063207586","https://openalex.org/W2075196907","https://openalex.org/W2108471572","https://openalex.org/W2115279806","https://openalex.org/W2134359334","https://openalex.org/W2156320702","https://openalex.org/W2158500189","https://openalex.org/W2284651264","https://openalex.org/W2414508679","https://openalex.org/W2580739402","https://openalex.org/W2951912712","https://openalex.org/W4297614019"],"related_works":["https://openalex.org/W2580415238","https://openalex.org/W1965300844","https://openalex.org/W2336479946","https://openalex.org/W2550737813","https://openalex.org/W4242043736","https://openalex.org/W2568229981","https://openalex.org/W4238786032","https://openalex.org/W2083418568","https://openalex.org/W2014396085","https://openalex.org/W3173489706"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2008790685","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
